Search

Chat With Us

    Cancer Immunotherapy with Placement Year
    Go to University of Hertfordshire
    University of Hertfordshire

    Cancer Immunotherapy with Placement Year

    University of Hertfordshire

    University of Hertfordshire

    flag

    United Kingdom, Hatfield

    University RankQS Ranking
    888

    Key Facts

    Program Level

    Master by Course Work

    Study Type

    Full Time

    Delivery

    On Campus

    Course Code

    H36

    Campuses

    University of Hertfordshire

    Hatfield

    Program Language

    English

    Start & Deadlines

    Next Intake Deadlines21-Sep-2024
    Apply to this program

    Go to the official application for the university

    Duration 2 year(s)
    Tuition Fee
    GBP 17,950  / year
    Next Intake 21-Sep-2024

    Cancer Immunotherapy with Placement Year

    About

    Why choose this course?

    • You'll be taught by our expert staff and innovative speakers from the biopharmaceutical industry.
    • Our modern Science Building provides excellent facilities for laboratory experiments, including DNA and genomic analysis eg QPCR, protein and proteomic science (eg MALDI-ToF), cell culture and Enzyme-based assays, isolated tissue studies and immunohistochemistry
    • When you graduate, you'll be equipped to work in a broad range of fields including medical or pharmaceutical research and development, clinical trials, public health and epidemiology, academia research, medical writing and science journalism, education, or patent law
    • We adopt a blended learning approach to teaching, focussing on problem-based scenarios so you can develop strong critical analysis skills. You'll benefit from exposure to practical techniques and guaranteed laboratory-based research projects
    • If successful you will have the opportunity to apply for a 12-month placement. If you are not successful in finding placement position then you can transfer to MSc Cancer Immunotherapy Advanced Research route.

    What will I study?

    You'll benefit from the research interests of the Bioscience Research Group. These include studies of the tumour microenvironment and communication with infiltrating immune cells, the methods tumours employ to diminish the effectivity of immune effector mechanisms and how tumours communicate using extracellular vesicles with pre-metastatic sites. We'll cover topics such as adoptive T cell therapy, tumour-associated macrophages, NK cells, monoclonal antibodies in cancer therapy, vaccines, microbial cancer therapies and immune checkpoint blockade.

    Teaching will be delivered through lectures, tutorials and practical classes. You'll immerse yourself in a research project which utilises problem-based and self-directed learning. You'll explore case studies to gain a strong critical understanding. Through your research projects, carried out in our innovative Science Building and supervised by world-leading researchers, you'll be trained in data collection, analysis and its interpretation. You'll also benefit from expert external speakers from the biopharmaceutical industry.

    About the course

    The use of the immune system in cancer therapy is a prevailing ambition in the field. You'll gain expert knowledge of the numerous ways cancers and the immune system interact so you can learn how cancer immunotherapies are developed. We'll provide a thorough understanding of immune effector mechanisms and cancer biology. You'll develop a range of personal skills through self-directed learning and our problem-based approach to teaching.

    Alternatively, consider taking our other MSc Cancer Immunotherapy routes:

    • MSc Cancer Immunotherapy
    • MSc Cancer Immunotherapy with Advanced Research

    Disciplines

    School of Life and Medical Sciences

    Requirements

    Entry Requirements

    Completion of a four year bachelors degree with GPA 2.4 or above.

    Career

    What job can I get?

    You could make a valuable contribution to the ambitious work of cancer immunologists and play a key role in the activation of immune effector mechanisms for cancer therapy. Your skills and knowledge will be sought after in a range of careers in the immunotherapy industries. For example, Roche, Merck, Astra Zeneca and small to medium-sized enterprises. You could work in medical or pharmaceutical research and development, clinical trials, public health and epidemiology, academia research, medical writing and science journalism, education, or patent law. Alternatively, you may use your MSc Cancer Immunotherapy with Advanced Research to underpin an application to study for a research degree such as MRes, MSc by Research, or a PhD in a related field.

    Fee Information

    Tuition Fee

    GBP 17,950 

    How to Apply

    Download the direct application form (PDF - 0.19 Mb)

    Please note: You must download the application form to your computer before you complete it. If you complete the form in the browser window, the information you have entered may be lost when the form is saved.

    When you have completed your pdf application form, please send it to:

    admppc@herts.ac.uk

    Complex Admissions
    University of Hertfordshire

    Hatfield
    Hertfordshire
    AL10 9AB
    UK

    University of Hertfordshire

    Cancer Immunotherapy with Placement Year

    University of Hertfordshire

    [object Object]

    United Kingdom,

    Hatfield

    Similar Programs

    Other interesting programs for you

    Find More Programs
    Wishlist